Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 8—August 2010

Perspective

Hantavirus Infections in Humans and Animals, China

Yong-Zhen ZhangComments to Author , Yang Zou, Zhen F. Fu, and Alexander Plyusnin
Author affiliations: State Key Laboratory for Infectious Disease Control and Prevention, Beijing, People’s Republic of China (Y.-Z. Zhang, Y. Zou); University of Georgia, Athens, Georgia, USA (Z.F. Fu); University of Helsinki, Helsinki, Finland (A. Plyusnin)

Main Article

Table 3

Inactivated hantavirus vaccines used in China, 1995–2010

Virus Cell culture used Vaccination procedure* Protection, %
Hantaan Mongolian gerbil kidney 3 + 1 >90
Seoul Golden hamster kidney 2 + 1 >95
Hantaan Suckling mouse brain 3 + 1 >90
Hantaan/Seoul Mongolian gerbil kidney 2 + 1 >95
Hantaan/Seoul Vero 2 + 1 >85†

*No. doses + no. boosters.
†Seroconversion rate of human hantavirus antibody determined by plaque-reduction neutralization test.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO